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Inflammation is a risk factor for the development and progression of colorectal cancer. Although the 
use of anti-inflammatory medications has been associated with better survival for patients with 
colorectal cancers, little is known about the genetic contribution to inflammation on disease 
prognosis. 
Recently, Anna Coghill and colleagues from the Public Health Sciences Division were some of the 
first to investigate the effect of genetic variation in genes that regulate inflammation on colorectal 
cancer survival. Specifically, the group genotyped single-nucleotide polymorphisms (SNPs) in 5 
genes that help regulate key inflammatory pathways, the prostaglandin synthesis pathway and the 
NFĸβ pathway, among 426 patients with a primary, invasive colorectal cancer identified from the 
Puget Sound Surveillance Epidemiology and End Results Registry. 
Of the 5 genes tested (PTGS-1 (COX-1), PTG-2 (COX-2), MRP4, NFĸβ, and IĸBKβ), variation in two 
genes was significantly associated with disease prognosis. Three PTGS-1 (COX-1) SNPs were 
associated with significantly increased risk of colorectal cancer mortality, while one variant was 
associated with an approximately 50% lower risk of death due to colorectal cancer. 
TwoIĸBKβ variants were also identified as being significantly associated with colorectal cancer 
survival. The findings may be due, in part, to the more advanced stage of disease at diagnosis 
observed among patients with certain genetic variants. Future research is also needed to determine 
whether the identified variants alter protein expression in these crucial inflammatory pathways. 
The identified SNPs provide an excellent beginning for further research to better understand how the 
inherited variation in inflammation-related genes could help refine the prediction of patient outcomes 
and aid the identification of new targets for therapy. 
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